Investigation of a New 2-piece Ostomy Product in People With an Ileostomy or Colostomy

August 18, 2016 updated by: Coloplast A/S
The purpose of this study is to investigate the influence of a new ostomy product on the peristomal fit for people with an ileo- or colostomy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Soeborg, Denmark, 2860
        • Trial Form Support ApS (TFS)
      • Berlin, Germany, 12203
        • Charité - Universitätsmedizin Berlin, Klinik für Allgemein-, Gefäß- und Thoraxchirurgie
      • Hamburg, Germany, 22045
        • SIEWA Coloplast Homecare
      • Groningen, Netherlands, 9713G12
        • QPS Netherlands
      • Larvik, Norway, 3269
        • Sykepleierklinikken A/S, Larvik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have given written informed consent and in DK: signed a letter of authority
  • Be at least 18 years of age and have full legal capacity
  • Have had their ileostomy or colostomy for at least 3 months
  • Able to use a baseplate size 15 to 40 mm
  • Be able to handle the product themselves
  • Normally experience faeces under the baseplate at least 3 times during 2 weeks
  • Currently using a 2-piece flat product with mechanical coupling
  • Willing to test both the Coloplast test product and the comparator product
  • Willing to use an open bag size maxi during the investigation
  • Willing to use Coloplast test product and comparator products without initial use of accessories (except tube paste / belt)
  • Willing to use at least 1 baseplate every 3rd day during the investigation
  • Is able to use a custom cut product
  • Be suitable for participating in the investigation

Exclusion Criteria:

  • Are currently receiving or have within the past 2 months received radio-and/or chemotherapy (low doses chemotherapy are allowed for other indications than cancer)
  • Are currently receiving or have within the past month received topical steroid treatment in the peristomal skin area (lotion or spray). Systemic steroid (tablet/injection) treatment are allowed
  • Are pregnant or breastfeeding
  • Are participating in other interventional clinical investigations or have previously participated in this investigation
  • Use irrigation during the investigation (flush the intestines with water)
  • Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin (assessed by the investigator)
  • Have a loop ostomy
  • Have known hypersensitivity towards any of the products used in the investigation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Coloplast Test Product then Comparator
The subject first tests the Coloplast Test Product and then tests the Comparator
A new 2-piece ostomy appliance developed by Coloplast A/S
Comparator is a Hollister FlexWear baseplate (ileostomy) or a Hollister SoftFlex baseplate (colostomy) both used with a Hollister open bag.
EXPERIMENTAL: Comparator then Coloplast Test Product
The subject first tests the Comparator and then tests the Coloplast Test Product.
A new 2-piece ostomy appliance developed by Coloplast A/S
Comparator is a Hollister FlexWear baseplate (ileostomy) or a Hollister SoftFlex baseplate (colostomy) both used with a Hollister open bag.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fit to the Peristomal Area, Measured by a 5-point Scale Ranging From "Very Poor" to "Very Good".
Time Frame: 21 +/- 3 days
Subjects will evaluate the fit to body for each product by answering the question "How was the baseplates ability to fit to the body contours in the area around the stoma?". The question is answered with a 5-point scale ranging from "very poor" to "very good".
21 +/- 3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (ACTUAL)

May 1, 2015

Study Completion (ACTUAL)

May 1, 2015

Study Registration Dates

First Submitted

February 9, 2015

First Submitted That Met QC Criteria

February 11, 2015

First Posted (ESTIMATE)

February 12, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

October 11, 2016

Last Update Submitted That Met QC Criteria

August 18, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CP255

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colostomy

Clinical Trials on Coloplast Test Product

Subscribe